FUJIFILM Holdings Corp (FJI.DU)
| Previous close | 19.73 |
| Open | 19.65 |
| Bid | 19.82 x 0 |
| Ask | 20.08 x 0 |
| Day's range | 19.65 - 19.77 |
| 52-week range | 15.53 - 21.45 |
| Volume | |
| Avg. volume | 8 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Globe NewswireFujifilm Healthcare Europe launches lifelike ESD training simulator EndoGel
RATINGEN, Germany, April 19, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Europe GmbH is pleased to announce the launch of EndoGel, a training model designed for performing Endoscopic Submucosal Dissection (ESD) and Peroral Endoscopic Myotomy (POEM) procedures. This innovative simulator, available in two versions - EndoGel for ESD and EndoGel for ESD/POEM - represents a significant advance in endoscopic training. This simulator aims to improve the skills of endoscopy professionals across Europe
- Business Live
More than 120 jobs at risk as major North East employer launches restructure
A total of 126 jobs are potentially set to go at the three North-east Fujifilm Diosynth Biotechnologies UK sites
Globe NewswireFujifilm Healthcare Europe partners with R Zero to bring next-gen training simulation technology to European endoscopists
mikoto Colonoscopy training simulator by R ZERO Inc. This portable training simulator offers multiple polyps, a realistic colon texture, four levels of difficulty and the recording of multiple procedure metrics. RATINGEN, Germany, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Fujifilm Healthcare Europe GmbH has announced a strategic partnership with R Zero for the exclusive distribution of mikoto, a state-of-the-art endoscopy simulation technology, throughout Europe. This collaboration aims at providing tra
